Keio Prize In Medicine For Development Of Molecular Target Lung Cancer Drug
This article was originally published in PharmAsia News
Executive Summary
Keio University announced September 10 it has awarded this year’s Keio Medical Science Prize for outstanding achievement in the field of life science and medicine to Jichi Medical University’s Hiroyuki Mano and U.S. National Cancer Institute Chief of Surgery Steven Rosenburg.
You may also be interested in...
New EU Filings
Obecabtagene autoleucel, Autolus Therapeutics’s investigational treatment for relapsed or refractory B cell precursor acute lymphoblastic leukemia, is among the latest products that have been filed for review by the European Medicines Agency for potential EU marketing approval.
Novartis Hires Ex-BMS Chief As It Pursues US Growth Strategy
The Swiss pharma company is looking to tap into the experience of ex-BMS leader Giovanni Caforio to help further it US-first commercial strategy.
Maxwellia Delivers Two UK Menstrual Health Rx-To-OTC Switches
UK switch specialist Maxwellia delivers two “me too” reclassifications in the area of women's health: Evana Heavy Period Relief and Ultravana Period Pain Relief.